Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-06 | Verrica Pharmaceuticals Inc. | Kirby John J.
(Interim CFO) |
A | Common Stock | A | 54267 | $0.00 - $0.00 | $0 |
| 2024-09-19 | Verrica Pharmaceuticals Inc. | Manning Paul B
(Director) |
G | Common Stock | D | 5351221 | $0.00 - $0.00 | $0 |
| 2024-07-22 | Verrica Pharmaceuticals Inc. | White Ted
(PRESIDENT AND CEO) |
S | Common Stock | D | 32623 | $6.98 - $7.06 | $230,305 |
| 2024-07-22 | Verrica Pharmaceuticals Inc. | Bonaccorso Joe
(CHIEF COMMERCIAL OFFICER) |
S | Common Stock | D | 25576 | $6.98 - $7.06 | $180,556 |
| 2024-07-22 | Verrica Pharmaceuticals Inc. | Goldenberg Gary
(Chief Medical Officer) |
S | Common Stock | D | 18507 | $6.98 - $7.06 | $130,652 |
| 2024-07-22 | Verrica Pharmaceuticals Inc. | Hayes Christopher G.
(CHIEF LEGAL OFFICER) |
S | Common Stock | D | 21740 | $6.98 - $7.06 | $153,476 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |